Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health

Neonorm Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool formation, gut hydration, and bowel health Expansion builds on Jaguar's focus on sustainably derived, plant-based gastrointestinal products for people and animals SAN FRANCISCO, CA / ACCESS Newswire / May 4, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced the planned launch of Neonorm Dog, a new extension of the Company's Neonorm franchise for companion animals. Neonorm Dog is designed to provide dog owners with access to a plant-based, non-prescription product intended to support normal stool formation, gut hydration, and bowel health in dogs.